Eva De Lago

Dr. Eva De Lago

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Brain Research
Verified
Journal Article
Closed access
MGMoisés García-Arencibia
Moisés García-Arencibia
SGSara González
Sara González
ELEva De Lago
Eva De Lago
JRJosé A. Ramos
José A. Ramos
RMRaphael Mechoulam
Raphael Mechoulam
JFJavier Fernández-Ruiz
Javier Fernández-Ruiz

1 November 2005 in Neurobiology of Disease
Verified
Journal Article
Closed access
ACAna Cabranes
Ana Cabranes
KVKaterina Venderova
Katerina Venderova
ELEva De Lago
Eva De Lago
FFFilomena Fezza
Filomena Fezza
ASAntonio Sánchez
Antonio Sánchez
JFJavier Fernández-Ruiz
Javier Fernández-Ruiz

1 May 2004 in Brain Research
Verified
Journal Article
Closed access
ELEva De Lago
Eva De Lago
RMRosario de Miguel
Rosario de Miguel
Isabel Lastres-BeckerIsabel Lastres-Becker
Isabel Lastres-Becker
JRJosé A Ramos
José A Ramos
JFJavier Fernández-Ruiz
Javier Fernández-Ruiz

10 February 2010 in Expert Opinion on Therapeutic Targets
Verified
Journal Article
Closed access
JFJavier Fernández-Ruiz
Javier Fernández-Ruiz
CGConcepción García
Concepción García
OSOnintza Sagredo
Onintza Sagredo
MGMaría Gómez-Ruiz
María Gómez-Ruiz
ELEva De Lago
Eva De Lago
Importance of the field: Cannabinoids have been proposed as clinically promising neuroprotective molecules, based on their capability to normalize glutamate homeostasis, reducing excitotoxicity, to inhibit calcium influx, lowering intracellular levels and the subsequent activation of calcium-dependent destructive pathways, and to reduce the generation of reactive oxygen intermediates or to limit their toxicity, decreasing oxidative injury. Cannabinoids are also able to decrease local inflammatory events by acting on glial processes that regulate neuronal survival, and to restore blood supply by reducing vasocontriction produced by several endothelium-derived factors.Areas covered in this review: Current literature supporting these neuroprotective effects, particularly evidence generated during the last ten years, concentrating on targets within the cannabinoid signaling system that facilitate these effects. Acute or chronic neurodegenerative disorders where cannabinoids have shown neuroprotective effect.W...

1 January 2004 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ELEva De Lago
Eva De Lago
ALAlessia Ligresti
Alessia Ligresti
GOGiorgio Ortar
Giorgio Ortar
EMEnrico Morera
Enrico Morera
ACAna Cabranes
Ana Cabranes
Vincenzo Di MarzoVincenzo Di Marzo
Vincenzo Di Marzo

23 June 2007 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
OSOnintza Sagredo
Onintza Sagredo
MGMoisés García-Arencibia
Moisés García-Arencibia
ELEva De Lago
Eva De Lago
SFSimone Finetti
Simone Finetti
ADAlessandra Decio
Alessandra Decio
JFJavier Fernández-Ruiz
Javier Fernández-Ruiz